Waters Research and Development Expenses 2010-2023 | WAT
Waters annual/quarterly research and development expenses history and growth rate from 2010 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Waters research and development expenses for the quarter ending December 31, 2023 were $0.044B, a 8.06% decline year-over-year.
- Waters research and development expenses for the twelve months ending December 31, 2023 were $0.175B, a 0.71% decline year-over-year.
- Waters annual research and development expenses for 2023 were $0.175B, a 0.71% decline from 2022.
- Waters annual research and development expenses for 2022 were $0.176B, a 4.65% increase from 2021.
- Waters annual research and development expenses for 2021 were $0.168B, a 19.59% increase from 2020.
| Waters Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $175 |
| 2022 | $176 |
| 2021 | $168 |
| 2020 | $141 |
| 2019 | $143 |
| 2018 | $143 |
| 2017 | $133 |
| 2016 | $125 |
| 2015 | $119 |
| 2014 | $108 |
| 2013 | $101 |
| 2012 | $96 |
| 2011 | $92 |
| 2010 | $84 |
| 2009 | $77 |
| Waters Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $44 |
| 2023-09-30 | $42 |
| 2023-06-30 | $46 |
| 2023-03-31 | $43 |
| 2022-12-31 | $48 |
| 2022-09-30 | $43 |
| 2022-06-30 | $44 |
| 2022-03-31 | $40 |
| 2021-12-31 | $43 |
| 2021-09-30 | $42 |
| 2021-06-30 | $45 |
| 2021-03-31 | $38 |
| 2020-12-31 | $40 |
| 2020-09-30 | $35 |
| 2020-06-30 | $31 |
| 2020-03-31 | $35 |
| 2019-12-31 | $37 |
| 2019-09-30 | $34 |
| 2019-06-30 | $36 |
| 2019-03-31 | $35 |
| 2018-12-31 | $38 |
| 2018-09-30 | $35 |
| 2018-06-30 | $36 |
| 2018-03-31 | $34 |
| 2017-12-31 | $35 |
| 2017-09-30 | $34 |
| 2017-06-30 | $33 |
| 2017-03-31 | $31 |
| 2016-12-31 | $33 |
| 2016-09-30 | $30 |
| 2016-06-30 | $33 |
| 2016-03-31 | $29 |
| 2015-12-31 | $28 |
| 2015-09-30 | $31 |
| 2015-06-30 | $31 |
| 2015-03-31 | $29 |
| 2014-12-31 | $29 |
| 2014-09-30 | $27 |
| 2014-06-30 | $27 |
| 2014-03-31 | $25 |
| 2013-12-31 | $27 |
| 2013-09-30 | $24 |
| 2013-06-30 | $25 |
| 2013-03-31 | $25 |
| 2012-12-31 | $25 |
| 2012-09-30 | $24 |
| 2012-06-30 | $24 |
| 2012-03-31 | $23 |
| 2011-12-31 | $24 |
| 2011-09-30 | $23 |
| 2011-06-30 | $23 |
| 2011-03-31 | $22 |
| 2010-12-31 | $23 |
| 2010-09-30 | $21 |
| 2010-06-30 | $21 |
| 2010-03-31 | $20 |
| 2009-12-31 | $20 |
| 2009-09-30 | $19 |
| 2009-06-30 | $20 |
| 2009-03-31 | $18 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.719B | $2.956B |
| Waters Corp. is an analytical instrument manufacturer and offers practical and sustainable products for laboratory-dependent organizations. Moreover, Waters provides analytical workflow solutions based on mass spectrometry (MS), liquid chromatography (LC) and thermal analysis technologies. The company's products are used by pharmaceutical, life science, biochemical, industrial, academic and government customers, working in research and development, quality assurance and other laboratory applications. The company operates in Asia, Americas and Europe. Waters organizes its business into two operating segments: Waters Division and TA Division. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $225.480B | 27.32 |
| Intuitive Surgical (ISRG) | United States | $135.098B | 81.39 |
| Edwards Lifesciences (EW) | United States | $51.040B | 33.22 |
| DexCom (DXCM) | United States | $49.691B | 75.27 |
| IQVIA Holdings (IQV) | United States | $41.731B | 24.21 |
| IDEXX Laboratories (IDXX) | United States | $41.543B | 48.69 |
| Alcon (ALC) | Switzerland | $39.902B | 28.59 |
| STERIS (STE) | Ireland | $22.980B | 26.85 |
| Hologic (HOLX) | United States | $17.636B | 19.73 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.555B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.711B | 14.84 |
| ShockWave Medical (SWAV) | United States | $12.404B | 77.19 |
| Sysmex ADR (SSMXY) | Japan | $10.586B | 33.20 |
| Teleflex (TFX) | United States | $9.765B | 15.20 |
| Globus Medical (GMED) | United States | $8.630B | 25.30 |
| Penumbra (PEN) | United States | $7.938B | 90.21 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.458B | 0.00 |
| TransMedics (TMDX) | United States | $4.349B | 412.62 |
| Integer Holdings (ITGR) | United States | $3.776B | 22.81 |
| LivaNova (LIVN) | United Kingdom | $3.311B | 19.66 |
| PROCEPT BioRobotics (PRCT) | United States | $3.265B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.865B | 19.66 |
| Tandem Diabetes Care (TNDM) | United States | $2.837B | 0.00 |
| Inari Medical (NARI) | United States | $2.650B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.582B | 21.84 |
| RxSight (RXST) | United States | $2.175B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.065B | 9.01 |
| Veracyte (VCYT) | United States | $1.720B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.558B | 0.00 |
| Artivion (AORT) | United States | $0.967B | 92.80 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.913B | 17.75 |
| OPKO Health (OPK) | United States | $0.878B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.817B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
| Paragon 28 (FNA) | United States | $0.673B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.628B | 21.31 |
| SiBone (SIBN) | United States | $0.618B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.564B | 0.00 |
| IRadimed (IRMD) | United States | $0.538B | 30.11 |
| Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.395B | 0.00 |
| Nevro (NVRO) | United States | $0.374B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.329B | 11.24 |
| Treace Medical Concepts (TMCI) | United States | $0.281B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.270B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
| AxoGen (AXGN) | United States | $0.253B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.245B | 0.00 |
| NeuroPace (NPCE) | United States | $0.245B | 0.00 |
| 908 Devices (MASS) | United States | $0.226B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.183B | 0.00 |
| CVRx (CVRX) | United States | $0.166B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.163B | 8.27 |
| ClearPoint Neuro (CLPT) | United States | $0.160B | 0.00 |
| Accuray (ARAY) | United States | $0.157B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.103B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.096B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.089B | 18.62 |
| Neuronetics (STIM) | United States | $0.077B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.063B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.060B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| InspireMD (NSPR) | Israel | $0.056B | 0.00 |
| DarioHealth (DRIO) | United States | $0.052B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.050B | 0.00 |
| Vasomedical (VASO) | United States | $0.050B | 9.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| LENSAR (LNSR) | United States | $0.044B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.024B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |